Abstract
Accumulation of substantial numbers of monocyte/macrophages, as well as activated T lymphocytes, in focal areas of arterial intima appears to be a hallmark of atherogenesis. Our report demonstrated that lysophosphatidylcholine (lyso-PC), a polar phospholipid component that is increased in atherogenic lipoproteins, such as oxidized LDL and remnants lipoproteins in diabetic and type III hyperlipidemic patients, can upregulate adhesion molecules for monocytes and T lymphocytes, and growth factors, such as heparin-binding epidermal growth factor-like growth factor and PDGF-A and B chains. Recently we identified the novel receptor for oxidized LDL, named Lox-1. Therefore in this paper we summarize the importance of the interaction between oxidized LDL and its receptor, LOX-1 in terms of early stage of atherogenesis.
Original language | English |
---|---|
Pages (from-to) | 123-126 |
Number of pages | 4 |
Journal | Diabetes Research and Clinical Practice |
Volume | 45 |
Issue number | 2-3 |
DOIs | |
Publication status | Published - 1999 Sept |
Externally published | Yes |
Keywords
- Lox-1
- Lysophosphatidylcholine
- Monocyte adhesion molecules
- Oxidized LDL
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology